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Purpose:  In addition to regulating body weight, leptin is also recognized for its role in the regulation of immune function 
and inflammation. The purpose of this study was to investigate the effect of leptin on Prevotella (P.) intermedia lipopolysaccha-
ride (LPS)-induced tumor necrosis factor (TNF)-α production in differentiated THP-1 cells, a human monocytic cell line.
Methods:  LPS from P. intermedia ATCC 25611 was prepared by the standard hot phenol-water method. THP-1 cells were incu-
bated in the medium supplemented with phorbol myristate acetate to induce differentiation into macrophage-like cells. The 
amount of TNF-α and interleukin-8 secreted into the culture medium was determined by enzyme-linked immunosorbent 
assay (ELISA). TNF-α and Ob-R mRNA expression levels were determined by semi-quantitative reverse transcription-poly-
merase chain reaction analysis.
Results:  Leptin enhanced P. intermedia LPS-induced TNF-α production in a dose-dependent manner. Leptin modulated P. 
intermedia LPS-induced TNF-α expression predominantly at the transcriptional level. Effect of leptin on P. intermedia LPS-in-
duced TNF-α production was not mediated by the leptin receptor.
Conclusions:  The ability of leptin to enhance P. intermedia LPS-induced TNF-α production may be important in the estab-
lishment of chronic lesion accompanied by osseous tissue destruction observed in inflammatory periodontal disease. 
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INTRODUCTION
Periodontal disease is a chronic inflammatory process ac-
companied by destruction of surrounding connective tissue 
and alveolar bone, and sometimes loss of teeth [1]. The pri-
mary causative agents of periodontal disease are particular 
gram-negative anaerobic bacteria that accumulate in the gin-
gival sulcus. Prevotella (P.) intermedia is a major periodontal 
pathogen that is dominant in the periodontal pockets of pa-
tients with adult periodontitis [2]. This bacterium has also been 
frequently recovered from subgingival flora in patients with 
acute necrotizing ulcerative gingivitis [3] and pregnancy gin-
givitis [4].
Lipopolysaccharide (LPS) is a major constituent of the outer 
membrane of gram-negative bacteria, including P. intermedia. 
It has the ability to trigger a number of host cells, especially 
mononuclear phagocytes, to produce and release a wide vari-
ety of pharmacologically active mediators, including inter-
leukin (IL)-1β, IL-6, IL-8, and, most importantly, tumor necro-
sis factor alpha (TNF-α) [5].
Leptin, the 16-kDa nonglycosylated protein encoded by the 
ob gene, is synthesized mainly by adipocytes and plays a cru-
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cial role in the homeostasis of body weight by regulating food 
intake and energy expenditure, through its action on the hy-
pothalamus [6-8]. In addition to regulating body weight, leptin 
is also recognized for its role in the regulation of angiogene-
sis [9], hematopoiesis [10], reproduction [11], immune func-
tion [12], and most importantly, inflammation [13]. 
Leptin has been classified as a cytokine because it shows ter-
tiary structure similar to the class of long-chain helical cytok-
ines that includes IL-6, IL-11, and leukemia inhibitory factor 
[14]. The biological activities of leptin are mediated through 
the interaction with its specific cell surface-leptin receptor, Ob-
R, which exists in multiple isoforms sharing the same extracel-
lular domain but differing in the length of transmembrane 
coding regions [12,15]. Leptin and Ob-R have been identified 
in various tissues and organs including the hypothalamus, 
adipose tissue, and gastric and intestinal mucosa, as well as 
in oral mucosa and the acinar cells of salivary glands [15-18]. 
The presence of leptin and Ob-R in oral mucosa and salivary 
glands suggests that the activity of leptin is also of signifi-
cance to diseases affecting the oral cavity. The purpose of this 
study was to investigate the effect of leptin on P. intermedia 
LPS-induced TNF-α production in differentiated THP-1 cells, 
a human monocytic cell line.
MATERIALS AND METHODS
Bacteria and culture conditions
P. intermedia ATCC 25611 was used throughout. It was grown 
anaerobically on the surface of enriched Trypticase soy agar 
containing 5% (v/v) sheep blood, or in GAM broth (Nissui, 
Tokyo, Japan) supplemented with 1 μg/mL menadione and 5 
μg/mL hemin. Culture purity was assessed by gram staining 
and plating on solid medium. 
LPS isolation
LPS was prepared from lyophilized P. intermedia ATCC 25611 
cells by the standard hot phenol-water method [19], and sub-
sequently purified by treatment with nuclease and proteinase 
K. The yield of LPS was about 0.26%. The protein content of 
the purified LPS, determined by the method of Markwell et 
al. [20], was less than 0.1%. Coomassie blue staining of over-
loaded sodium dodecyl sulfate (SDS)-polyacrylamide gels did 
not reveal any visible protein bands in the purified LPS, con-
firming the purity of the preparation (data not shown). 
Cell cultures
The human monocytic cell line THP-1 (American Type Cul-
ture Collection, Rockville, USA) was grown routinely in Nunc 
flasks in RPMI 1640 medium supplemented with 10% (v/v) 
heat inactivated FBS, 50 μM 2-mercaptoethanol, 1 mM sodi-
um pyruvate, 25 mM HEPES, 100 U/mL of penicillin, and 100 
μg/mL of streptomycin in a humidified chamber with 5% 
CO2/95% air at 37°C. The cells (5 × 10
5 cells/ml/well in 24-well 
culture plates) were incubated in the medium supplemented 
with 50 ng/mL of phorbol myristate acetate to induce differ-
entiation into macrophage-like cells. The cells were allowed 
to differentiate and adhere to plastic for 72 hours and washed 
three times with medium. Various concentrations of P. inter-
media LPS and leptin (R & D Systems, Minneapolis, USA) were 
then added and the cells were cultured for the indicated times, 
after which culture supernatants were collected and assayed 
for TNF-α. 
Measurement of TNF-α and IL-8 production
The amount of TNF-α and IL-8 secreted into the culture 
medium was determined by enzyme-linked immunosorbent 
assay (ELISA) using a commercially available kit (OptEIA, BD 
Pharmingen, San Diego, USA) according to protocols recom-
mended by the manufacturer. The sensitivity of the assay was 
7.8 pg/mL, according to the manufacturer. 
Reverse transcription-polymerase chain reaction (RT-PCR) 
and analysis of PCR products
Cells were plated in 100-mm tissue culture dishes, at a den-
Table 1.  Nucleotide sequences of probes used in RT-PCR assays and amplification conditions.
Oligonucleotide Sequence RT-PCR conditions
β-actin  Sense 5'-AAG AGA GGC ATC CTC ACC CT-3' 94°C-1 min/ 60°C-1 min/ 72°C-1 min; 35 cycles
Antisense 5'-TAC ATG GCT GGG GTG TTG AA-3'
TNF-α Sense 5'-TCA GCC TCT TCT CCT TCC TG-3' 94°C-1 min/ 60°C-1 min/ 72°C-1 min; 35 cycles 
Antisense 5'-TGA AGA GGA CCT GGG AGT AG-3' 
Ob-Ra Sense 5'-GAA GGA GTG GGA AAA CCA AAG-3' 94°C-1 min/ 54°C-1 min/ 72°C-1 min; 35 cycles
Antisense 5'-CCA CCA TAT GTT AAC TCT CAG-3' 
Ob-Rb Sense 5'-GAA GGA GTG GGA AAA CCA AAG-3'  94°C-1 min/ 54°C-1 min/ 72°C-1 min; 35 cycles
Antisense 5'-CAT AGG TTA CCT CAG TAC CCT C-3'
RT-PCR: reverse transcription-polymerase chain reaction, TNF: tumor necrosis factor. Journal of Periodontal
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sity of 5 × 10
6 cells per dish, and treated with various concen-
trations of P. intermedia LPS and leptin (R & D Systems, Min-
neapolis, USA) for the indicated periods of time. Following 
incubation, they were washed twice with phosphate buffered 
saline and collected by centrifugation. Total RNA was isolat-
ed with an RNeasy Mini Kit (Qiagen, Valencia, USA), accord-
ing to the manufacturer’s instructions. Synthesis of cDNA 
from the extracted RNA and subsequent amplification of the 
cDNA by RT-PCR were carried out with an AccuPower RT/
PCR Premix kit (Bioneer, Seoul, Korea) and thermal cycler 
(GeneAmp PCR system 2400, PE Applied Biosystems, Foster 
City, USA). β-actin served as internal control. The number of 
cycles that ensured nonsaturating PCR conditions was estab-
lished in preliminary experiments. Primer sequences and RT-
PCR conditions are listed in Table 1. The PCR-amplified prod-
ucts were run on a 1.5% agarose gel containing ethidium bro-
mide and visualized with UV light. The intensities of the PCR 
bands on gel photographs were quantified by densitometry. 
Statistical analysis
Statistical analysis was performed using Student’s paired t-
test with P<0.05 considered statistically significant. Data are 
expressed as means±SD of three independent experiments. 
RESULTS
Effect of leptin on production of TNF-α and IL-8
As shown in Fig. 1A, leptin induced a weak increase in 
TNF-α production in differentiated THP-1 cells, which be-
came significant at 10 μg/mL. Moreover, P. intermedia LPS-in-
duced TNF-α production was enhanced by leptin in a dose-
dependent manner with a significant effect already seen at 
0.01 μg/mL compared with LPS alone (Fig. 1B). Leptin at its 
concentration of 10 μg/mL elicited up to 3.25-fold increase in 
P. intermedia LPS-induced TNF-α production. Leptin increased 
IL-8 production without LPS with a significant effect at more 
than 1 μg/mL (Fig. 1A). However, P. intermedia LPS-induced 
IL-8 production was unaltered by leptin (Fig. 1B).
Effect of leptin on TNF-α mRNA expression 
To investigate whether leptin modulates P. intermedia LPS-
induced TNF-α production at the gene level, TNF-α mRNA 
levels were determined by semi-quantitative RT-PCR analy-
sis. As shown in Fig. 2A, leptin induced a concentration-de-
pendent increase in TNF-α mRNA expression in differentiat-
ed THP-1 cells, which became significant at 1 μg/mL. More-
over, leptin potentiated P. intermedia LPS-induced expression 
of TNF-α mRNA in a dose-dependent manner (Fig. 2B).
Effect on leptin receptor expression
To verify whether the Ob-R is responsible for mediating 
the synergistic effect of leptin on P. intermedia LPS-induced 
TNF-α production in differentiated THP-1 cells, Ob-R mRNA 
expression levels were determined by semi-quantitative RT-
PCR analysis. The long (Ob-Rb) and short (Ob-Ra) leptin re-
ceptors were expressed in untreated and leptin-treated cells, 
Figure 1.  Effect of leptin on the release of tumor necrosis factor (TNF)-α and interleukin (IL)-8 by differentiated THP-1 cells. Cells were in-
cubated with increasing concentrations of leptin (0.01-10 μg/mL) in the absence (A) or presence (B) of Prevotella intermedia lipopolysaccha-
ride (LPS) (0.01 μg/mL). Supernatants were removed after 24 hours and assayed for TNF-α and IL-8. The results are means±SD of three in-
dependent experiments.
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while upregulation of Ob-R by P. intermedia LPS stimulation 
or its potentiation by leptin was not confirmed (Fig. 3). As 
shown in Fig. 3, the levels of expression of the leptin recep-
tors were similar in all samples.
DISCUSSION
Because production of TNF-α has been recognized as a 
marker in a variety of human diseases associated with in-
flammation [21], the effect of leptin on P. intermedia LPS-in-
duced TNF-α production in differentiated THP-1 cells, a hu-
man monocytic cell line, was studied. Macrophages are known 
to be the main producer of TNF-α and a dense infiltration of 
inflammatory cells, including macrophages, occurs in the 
gingival connective tissues of patients with periodontal dis-
ease [22].
Leptin levels are increased by inflammatory stimuli such as 
LPS and cytokines [23-25]. And, leptin enhances pro-inflam-
matory cytokine production and phagocytosis by macrophag-
es [26]. The plasma levels of leptin have been reported to in-
crease as periodontal disease progressed [27]. Conversely, it 
was shown that the leptin concentration is higher in healthy 
gingival tissue than in diseased tissue [28]. Further, the results 
of Karthikeyan and Pradeep [27] showed a strong negative cor-
relation between the GCF leptin concentration and periodon-
tal disease progression. Their results are in accordance with 
the study done by Johnson and Serio [29], who also showed 
that leptin concentration is correlated negatively with the 
probing pocket depth. The mechanism underlying the above 
findings is not known. Leptin may be used up as a substrate 
during inflammation.
The results of this study indicate that leptin potentiates P. 
intermedia LPS-induced TNF-α production in a dose-depen-
dent manner. Leptin modulated P. intermedia LPS-induced 
TNF-α expression predominantly at the transcriptional level. 
There is evidence to suggest that TNF-α plays a central role 
in the pathogenesis of periodontal disease. TNF-α has been 
found at high levels in gingival crevicular fluids and in gingival 
tissues from periodontally diseased sites over those in healthy 
sites [30,31]. Moreover, it was shown that TNF-α  has a strong 
potential to induce connective tissue degradation and alveolar 
bone resorption [32,33]. Furthermore, blockade of the activity 
of TNF-α was found to inhibit the inflammatory response 
and bone loss in a primate model of experimental periodon-
titis [34]. The ability of leptin to enhance P. intermedia LPS-in-
duced TNF-α production may be important in the establish-
ment of chronic lesion accompanied by osseous tissue de-
struction observed in inflammatory periodontal disease. 
To verify whether the mechanism behind the synergistic 
effect of leptin with P. intermedia LPS might be related to an 
increase in Ob-R expression, Ob-R mRNA expression levels 
were determined by semi-quantitative RT-PCR analysis. This 
study demonstrated the presence of the long and short leptin 
receptors in differentiated THP-1 cells. However, leptin recep-
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Figure 2.  Effect of leptin on the expression of tumor necrosis factor (TNF)-α mRNA in differentiated THP-1 cells. Cells were incubated with 
increasing concentrations of leptin (0.01-10 μg/mL) in the absence (A) or presence (B) of Prevotella intermedia lipopolysaccharide (LPS) (0.01 
μg/mL). See MATERIALS AND METHODS for further details. The polymerase chain reaction bands on a gel photograph in one of two sep-
arate experiments yielding similar results are shown.
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Figure 3.  Effect of leptin on the expression of Ob-Ra and Ob-Rb mRNA in differentiated THP-1 cells. Cells were incubated with increasing 
concentrations of leptin (0.01-10 μg/mL) in the absence (A) or presence (B) of Prevotella intermedia lipopolysaccharide (LPS) (0.01 μg/mL). See 
MATERIALS AND METHODS for further details. The polymerase chain reaction bands on a gel photograph in one of two separate experi-
ments yielding similar results are shown.Journal of Periodontal
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tors were not modulated by P. intermedia LPS or leptin. These 
results indicate that effect of leptin on P. intermedia LPS-in-
duced TNF-α production is not mediated by the leptin recep-
tor. The mechanism by which leptin potentiates P. intermedia 
LPS-induced TNF-α production remains to be elucidated.
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